Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zydus Lifesciences Limited ( (IN:ZYDUSLIFE) ) has shared an update.
Zydus Lifesciences Limited has announced, via newspaper publication, the opening of a special six-month window from July 7, 2025 to January 6, 2026 for re-lodgement of transfer requests for physical shares, in line with a Securities and Exchange Board of India (SEBI) circular issued on July 2, 2025. This facility applies to physical share transfer requests originally lodged before April 1, 2019 that were rejected and returned due to documentation or process deficiencies, allowing investors who missed the earlier March 31, 2021 deadline to resubmit with proper documents through the company or its registrar and share transfer agent, with transfers to be completed only in demat form and no requests accepted after January 6, 2026.
More about Zydus Lifesciences Limited
Zydus Lifesciences Limited is an India-based pharmaceuticals and life sciences company, engaged in the development, manufacturing and marketing of pharmaceutical products and therapies, with its registered office located in Ahmedabad, Gujarat. The company is listed on both BSE and the National Stock Exchange of India, reflecting its presence in the public capital markets and its engagement with a broad base of equity shareholders.
Average Trading Volume: 27,365
Technical Sentiment Signal: Hold
Current Market Cap: 923.2B INR
For detailed information about ZYDUSLIFE stock, go to TipRanks’ Stock Analysis page.